Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
5.18
+0.64 (14.10%)
At close: Dec 20, 2024, 4:00 PM
5.44
+0.26 (5.02%)
After-hours: Dec 20, 2024, 7:22 PM EST

Telomir Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
153---
Enterprise Value
153---
Debt / Equity Ratio
0.210.18-0.62-0.86
Quick Ratio
1.390.000.00-
Current Ratio
1.740.330.05-
Return on Equity (ROE)
-1752.69%-1045.36%--
Return on Assets (ROA)
-204.69%-102.18%--
Return on Capital (ROIC)
-243.60%-132.78%--
Buyback Yield / Dilution
-6.65%-1.77%--
Total Shareholder Return
-6.65%-1.77%--
Source: S&P Capital IQ. Standard template. Financial Sources.